FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 1 | 0 |
% | 0.00 | 0.00 | 0.00 | 100.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | Avoid |
[Dilip Davda] The company has shown just 20 months working with the last eight months reporting negative earnings. The company has a long gestation period to migrate to the main board as its post IPO equity remains small. The issue expenses indicate a fully structured IPO with pre-funding arrangements. It operates in a highly competitive and fragmented segment. Based on its financial data, the issue is exorbitantly priced. There is no harm in avoiding this issue. Read detail review...
Alkosign IPO Reviews, analysis and views by popular members. Read Alkosign Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|
Member | Review |
---|---|
No recommendation found. Be the first to post the
recommendation. |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|